Diary - News All news Adocia obtains additional financial resources to accelerate its growth

Adocia obtains additional financial resources to accelerate its growth

Establishment of a debt financing plan for a maximum amount of 15 million euros, with IPF Partners
First tranche of EUR 7.5 million is subscribed immediately
Current cash position above EUR 39 million as of October 14, 2019

Lyon, France, October 14, 2019 – 7:30 am CEST - Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, today announced that it has obtained additional resources from IPF Partners to finance its growth.